Neil J Glassford1, Johan Mårtensson2, Glenn M Eastwood3, Sarah L Jones4, Aiko Tanaka4, Erica Wilkman5, Michael Bailey6, Rinaldo Bellomo7. 1. Department of Intensive Care, Austin Hospital, Melbourne, VIC 3084, Australia; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Prahran, VIC 3004, Australia. Electronic address: neil.glassford@austin.org.au. 2. Department of Intensive Care, Austin Hospital, Melbourne, VIC 3084, Australia; Section of Anaesthesia and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. 3. Department of Intensive Care, Austin Hospital, Melbourne, VIC 3084, Australia; School of Nursing and Midwifery, Faculty of Health, Deakin University, Burwood, VIC 3125, Australia. 4. Department of Intensive Care, Austin Hospital, Melbourne, VIC 3084, Australia. 5. Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, Helsinki University Hospital, Helsinki, Finland. 6. Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Prahran, VIC 3004, Australia. 7. Department of Intensive Care, Austin Hospital, Melbourne, VIC 3084, Australia; Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Prahran, VIC 3004, Australia.
Abstract
PURPOSE: The purpose of the study is to understand what clinicians believe defines fluid bolus therapy (FBT) and the expected response to such intervention. METHODS: We asked intensive care specialists in 30 countries to participate in an electronic questionnaire of their practice, definition, and expectations of FBT. RESULTS: We obtained 3138 responses. Despite much variation, more than 80% of respondents felt that more than 250 mL of either colloid or crystalloid fluid given over less than 30 minutes defined FBT, with crystalloids most acceptable. The most acceptable crystalloid and colloid for use as FBT were 0.9% saline and 4% albumin solution, respectively. Most respondents believed that one or more of the following physiological changes indicates a response to FBT: a mean arterial pressure increase greater than 10 mm Hg, a heart rate decrease greater than 10 beats per minute, an increase in urinary output by more than 10 mL/h, an increase in central venous oxygen saturation greater than 4%, or a lactate decrease greater than 1 mmol/L. CONCLUSIONS: Despite wide variability between individuals and countries, clear majority views emerged to describe practice, define FBT, and identify a response to it. Further investigation is now required to describe actual FBT practice and to identify the magnitude and duration of the physiological response to FBT and its relationship to patient-centered outcomes.
PURPOSE: The purpose of the study is to understand what clinicians believe defines fluid bolus therapy (FBT) and the expected response to such intervention. METHODS: We asked intensive care specialists in 30 countries to participate in an electronic questionnaire of their practice, definition, and expectations of FBT. RESULTS: We obtained 3138 responses. Despite much variation, more than 80% of respondents felt that more than 250 mL of either colloid or crystalloid fluid given over less than 30 minutes defined FBT, with crystalloids most acceptable. The most acceptable crystalloid and colloid for use as FBT were 0.9% saline and 4% albumin solution, respectively. Most respondents believed that one or more of the following physiological changes indicates a response to FBT: a mean arterial pressure increase greater than 10 mm Hg, a heart rate decrease greater than 10 beats per minute, an increase in urinary output by more than 10 mL/h, an increase in central venous oxygen saturation greater than 4%, or a lactate decrease greater than 1 mmol/L. CONCLUSIONS: Despite wide variability between individuals and countries, clear majority views emerged to describe practice, define FBT, and identify a response to it. Further investigation is now required to describe actual FBT practice and to identify the magnitude and duration of the physiological response to FBT and its relationship to patient-centered outcomes.
Authors: Anders Perner; John Prowle; Michael Joannidis; Paul Young; Peter B Hjortrup; Ville Pettilä Journal: Intensive Care Med Date: 2017-05-03 Impact factor: 17.440
Authors: Jonathan A Silversides; Daniel F McAuley; Bronagh Blackwood; Eddy Fan; Andrew J Ferguson; John C Marshall Journal: J Intensive Care Soc Date: 2019-05-13
Authors: Arnaldo Dubin; Cecilia Loudet; Vanina S Kanoore Edul; Javier Osatnik; Fernando Ríos; Daniela Vásquez; Mario Pozo; Bernardo Lattanzio; Fernando Pálizas; Francisco Klein; Damián Piezny; Paolo N Rubatto Birri; Graciela Tuhay; Analía García; Analía Santamaría; Graciela Zakalik; Cecilia González; Elisa Estenssoro Journal: Ann Intensive Care Date: 2020-04-15 Impact factor: 6.925
Authors: Olof Wall; Salvatore Cutuli; Anthony Wilson; Glenn Eastwood; Adam Lipka-Falck; Daniel Törnberg; Rinaldo Bellomo; Maria Cronhjort Journal: PLoS One Date: 2022-03-24 Impact factor: 3.240